Astrazeneca reported 9.61B in Trade Debtors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
AstraZeneca AZN:LN 9.61B 562M
Astrazeneca AZN:US 9.61B 562M
Bristol Myers Squibb BMY:US $ 12540M 4029M
Canopy Growth Corp WEED:CN C$ 96.63M 183K
Catalent CTLT:US $ 1259M 80M
Corcept Therapeutics CORT:US $ 28.16M 0.99M
Eli Lilly And LLY:US $ 7672.4M 133.3M
Endo International Ordinary Shares ENDP:US $ 498.9M 13.24M
Genmab GEN:DC 3.19B 211M
GlaxoSmithKline GSK:LN 6.87B 1.93B
Horizon Pharma HZNP:US $ 673.31M 11.2M
JAZZ PHA JAZZ:US $ 594.03M 21.64M
Lannett LCI:US $ 101.21M 0.91M
Novartis NOVN:VX 8.91B 232M
Pacira Pharmaceuticals PCRX:US $ 91.1M 1M
Perrigo Ordinary Shares PRGO:US $ 777.1M 65.3M
Phibro Animal Health PAHC:US $ 156.56M 14.07M
Prestige Brands PBH:US $ 145.45M 6.12M
Supernus Pharmaceuticals SUPN:US $ 158.06M 12.91M
Teva Pharmaceutical Industries TEVA:US $ 4471M 218M
Valeant Pharmaceuticals VRX:CN $ 1566M 209M
Zoetis ZTS:US $ 1291M 69M